case report aspiration during anesthesia semaglutide 2023 Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence – einstein (São Paulo) Popular weight-loss drugs like Ozempic
Description
This decision should always be made with clinical guidance
Heres everything you need to know: Semaglutide is a groundbreaking treatment approved by the FDA for chronic weight management in adults with a BMI of 27 kg/m or greater who have at least one weight-related condition
Eur Med J (2015) 3(1):5765
The results of the sensitivity analyses supported the main findings
The FDA gave pharmacies wind-down periods - 60 days for 503A state-licensed pharmacies, 90 days for 503B outsourcing facilities
